The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular features and outcomes for patients receiving elranatamab for relapsed or refractory multiple myeloma in MagnetisMM-1.
 
Michael H. Tomasson
No Relationships to Disclose
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Caitlin Costello
Honoraria - Celgene; Janssen; Pfizer; Takeda
Consulting or Advisory Role - Celgene; Janssen; Pfizer; Takeda
Research Funding - Celgene; Janssen; Takeda
 
Noopur S. Raje
Honoraria - Medscape; Research to Practice
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Merck; Takeda
Research Funding - 2seventy bio
 
Moshe Y. Levy
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Sanofi; Seagen; Takeda
 
Bhagirathbhai R. Dholaria
Stock and Other Ownership Interests - Iovance Biotherapeutics; Syndax
Honoraria - Adaptive Biotechnologies; Curio Science; MJH Healthcare Holdings, LLC; Wiley
Consulting or Advisory Role - arivan research; Beam Therapeutics; Gamida Cell; Jazz Pharmaceuticals; Pluristem Therapeutics
Research Funding - Angiocrine Bioscience (Inst); Janssen Oncology (Inst); MEI Pharma (Inst); Orca Bio (Inst); Pfizer (Inst); poseida therapeutics (Inst); Takeda (Inst); WUGEN, Inc. (Inst)
 
Melhem M. Solh
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; Seagen
Research Funding - ADC Therapeutics; Partner Therapeutics
 
Michael A. Damore
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Sibo Jiang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Tao Xie
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Cynthia Basu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Athanasia Skoura
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Edward Michael Chan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Suzanne Trudel
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Research Funding - Amgen; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Pfizer
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
 
Cristina Gasparetto
Leadership - Celgene
Consulting or Advisory Role - Abbvie/Genentech; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Karyopharm Therapeutics; Oncopeptides; Sanofi
Research Funding - Abbvie (Inst); BMS (Inst); Karyopharm Therapeutics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Michael Chu
Honoraria - AstraZeneca; Bristol-Myers Squibb/Celgene; Gilead Sciences; Janssen Oncology; Roche; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Janssen
 
Andrew Peter Dalovisio
No Relationships to Disclose
 
Michael Sebag
Consulting or Advisory Role - BMSi; focus therapeutics; Gilead Sciences; Janssen; Janssen; Pfizer
Patents, Royalties, Other Intellectual Property - Patent but with no associated royalties or profit
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; Trillium Therapeutics
Consulting or Advisory Role - Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc